Hungary’s Richter says deal to buy Polpharma fails
Hungarian drug maker Richter Gedeon said on Tuesday its takeover of Poland’s Polpharma was not completed as scheduled on Monday, because Polpharma owner Genefar did not agree to the terms of the closure of the deal.
Richter made the announcement on the Budapest bourse’s website www.bet.hu, Richter said last week its plan to create central Europe’s biggest drug producer by taking over Polpharma would likely fail because Genefar had asked for additional payments and guarantees following a slide in the value of Richter’s stock which had been used to finance the deal. (Reuters)
ADVERTISEMENT
Investment Volume Falls 2.8% in Q1
Parl't Approves Amendments to Legislation on Judiciary
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
